Literature DB >> 20471734

Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Paul Muntner1, Suzanne E Judd, Marie Krousel-Wood, William M McClellan, Monika M Safford.   

Abstract

BACKGROUND: Low adherence to antihypertensive medication is an important barrier to achieving blood pressure control. Few data are available for medication adherence in adults with chronic kidney disease (CKD). STUDY
DESIGN: Cross-sectional. SETTING &amp; PARTICIPANTS: 3,936 and 9,129 participants with and without CKD using antihypertensive medication in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study, respectively. CKD was defined as albuminuria with albumin excretion>or=30 mg/g or estimated glomerular filtration rate<60 mL/min/1.73 m2. OUTCOMES: Medication adherence and uncontrolled hypertension. MEASUREMENTS: Medication adherence was assessed using a validated 4-item scale. Blood pressure was measured 2 times by trained staff.
RESULTS: In REGARDS participants with and without CKD, 1,426 (36.2%) and 2,421 (26.5%) had uncontrolled hypertension with blood pressure>or=140/90 mm Hg, and 2,656 (67.5%) and 5,627 (61.6%), >or=130/80 mm Hg. Also, 27.7% of those with CKD and 27.9% of those without CKD responded "yes" to ever forgetting to take their medication and 4.4% and 4.2%, respectively, responded yes to being careless about taking their medication. Also, 5.7% and 5.3% responded yes to missing taking medication when they felt better, and 4.2% and 3.6%, to missing it when they felt sick. Overall, 23.3% and 23.7% of participants with and without CKD responded yes to 1 adherence question, whereas 7.7% and 7.2%, respectively, responded yes to 2 or more adherence questions. In those with CKD, the multivariable adjusted ORs for uncontrolled hypertension (blood pressure>or=140/90 mm Hg) for individuals answering yes to 1 and 2 or more versus 0 adherence questions were 1.26 (95% CI, 1.05-1.51) and 1.49 (95% CI, 1.12-1.98), respectively. Analogous ORs for systolic/diastolic blood pressure>or=130/80 mm Hg were 1.06 (95% CI, 0.78-1.45) and 1.20 (95% CI, 0.88-1.64). LIMITATIONS: Pharmacy fill data were not available.
CONCLUSIONS: Individuals with CKD had similarly poor medication-taking behaviors as those without CKD. Copyright (c) 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471734      PMCID: PMC3659158          DOI: 10.1053/j.ajkd.2010.02.348

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  39 in total

1.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.

Authors:  R Horne; J Weinman
Journal:  J Psychosom Res       Date:  1999-12       Impact factor: 3.006

2.  Control of hypertension in adults with chronic kidney disease in the United States.

Authors:  Carmen A Peralta; Leroi S Hicks; Glenn M Chertow; John Z Ayanian; Eric Vittinghoff; Feng Lin; Michael G Shlipak
Journal:  Hypertension       Date:  2005-04-25       Impact factor: 10.190

3.  Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research.

Authors:  M Robin DiMatteo
Journal:  Med Care       Date:  2004-03       Impact factor: 2.983

4.  Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men.

Authors:  Miyong T Kim; Hae-Ra Han; Martha N Hill; Linda Rose; Mary Roary
Journal:  Ann Behav Med       Date:  2003-08

5.  Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.

Authors:  Gbenga Ogedegbe; Melanie Harrison; Laura Robbins; Carol A Mancuso; John P Allegrante
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

6.  Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.

Authors:  Philip S Wang; Rhonda L Bohn; Eric Knight; Robert J Glynn; Helen Mogun; Jerry Avorn
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Patient adherence and medical treatment outcomes: a meta-analysis.

Authors:  M Robin DiMatteo; Patrick J Giordani; Heidi S Lepper; Thomas W Croghan
Journal:  Med Care       Date:  2002-09       Impact factor: 2.983

Review 9.  Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.

Authors:  Marie Krousel-Wood; Sheila Thomas; Paul Muntner; Donald Morisky
Journal:  Curr Opin Cardiol       Date:  2004-07       Impact factor: 2.161

10.  Six-item screener to identify cognitive impairment among potential subjects for clinical research.

Authors:  Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie
Journal:  Med Care       Date:  2002-09       Impact factor: 2.983

View more
  40 in total

1.  Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.

Authors:  Tara I Chang; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2010-09       Impact factor: 8.860

2.  Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.

Authors:  Gabriel S Tajeu; Shia T Kent; Ian M Kronish; Lei Huang; Marie Krousel-Wood; Adam P Bress; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

3.  Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.

Authors:  Mayuree Tangkiatkumjai; Dawn-Marie Walker; Kearkiat Praditpornsilpa; Helen Boardman
Journal:  Clin Exp Nephrol       Date:  2016-07-20       Impact factor: 2.801

4.  Fistula first: recent progress and ongoing challenges.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

Review 5.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

6.  Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.

Authors:  Kailin L Hsu; Jeffrey C Fink; Jennifer S Ginsberg; Marni Yoffe; Min Zhan; Wanda Fink; Corinne M Woods; Clarissa J Diamantidis
Journal:  Am J Kidney Dis       Date:  2015-05-13       Impact factor: 8.860

7.  Kidney function and long-term medication adherence after myocardial infarction in the elderly.

Authors:  Tara I Chang; Manisha Desai; Daniel H Solomon; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-13       Impact factor: 8.237

8.  Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study.

Authors:  Paul Muntner; Jewell H Halanych; Kristi Reynolds; Raegan Durant; Suma Vupputuri; Victor W Sung; James F Meschia; Virginia J Howard; Monika M Safford; Marie Krousel-Wood
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04-22       Impact factor: 3.738

9.  Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Graziella D'Arrigo; Silvio Borrelli; Carlo Garofalo; Giovanna Stanzione; Michele Provenzano; Luca De Nicola; Giuseppe Conte; Roberto Minutolo; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-02       Impact factor: 8.237

10.  Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure.

Authors:  Paul Muntner; Emily B Levitan; Cara Joyce; Elizabeth Holt; Devin Mann; Suzanne Oparil; Marie Krousel-Wood
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-11-28       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.